Back to 
Zacks Investment Management
Zacks Investment Management
FATE
Showing 0 of 5 quarters
Position history for Zacks Investment Management's holdings in Fate Therapeutics, Inc.
No. Zacks Investment Management exited its FATE (Fate Therapeutics) position in Q4 2020. Its Q3 2020 13F listed 55,515 shares worth $2.2M. Zacks Investment Management first reported FATE in Q4 2019 and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.